Neil Herskowitz Biography and Net Worth

Director of Mustang Bio

Mr. Herskowitz has served as a member of our Board of Directors since August 2015. Mr. Herskowitz has served as the managing member of the ReGen Group of companies, located in New York, since 1998, which include ReGen Capital Investments LLC and Riverside Claims Investments LLC. He has also served as the President of its affiliate, Riverside Claims LLC, since June 2004. He serves as Chairman of the board of directors of Starting Point Services for Children, a not-for-profit corporation. Mr. Herskowitz received a B.B.A. in Finance from Bernard M. Baruch College in 1978.

What is Neil Herskowitz's net worth?: The estimated net worth of Neil Herskowitz is at least $60.16 as of December 30th, 2025. Mr. Herskowitz owns 145 shares of Mustang Bio stock worth more than $60 as of October 9th. This net worth estimate does not reflect any other assets that Mr. Herskowitz may own. Learn More about Neil Herskowitz's net worth.
How do I contact Neil Herskowitz?: The corporate mailing address for Mr. Herskowitz and other Mustang Bio executives is 95 Sawyer RD, Suite 110, Waltham, MA, 02453. Mustang Bio can also be reached via phone at (781) 652-4500 and via email at [email protected]. Learn More on Neil Herskowitz's contact information.
Has Neil Herskowitz been buying or selling shares of Mustang Bio?: Neil Herskowitz has not been actively trading shares of Mustang Bio over the course of the past ninety days. Most recently, Neil Herskowitz sold 247 shares of the business's stock in a transaction on Tuesday, December 30th. The shares were sold at an average price of $0.96, for a transaction totalling $237.12. Following the completion of the sale, the director now directly owns 145 shares of the company's stock, valued at $139.20. Learn More on Neil Herskowitz's trading history.
Who are Mustang Bio's active insiders?: Mustang Bio's insider roster includes Brian Achenbach (SVP), Adam Chill (Director), Neil Herskowitz (Director), David Jin (Director), and Manuel Litchman (CEO). Learn More on Mustang Bio's active insiders.
Are insiders buying or selling shares of Mustang Bio?: In the last twelve months, Mustang Bio insiders bought shares 1 times. They purchased a total of 247 shares worth more than $237.12. In the last twelve months, insiders at the sold shares 2 times. They sold a total of 251 shares worth more than $240.92. The most recent insider tranaction occured on December, 30th when Director David Jin bought 247 shares worth more than $237.12. Insiders at Mustang Bio own 4.0% of the company. Learn More about insider trades at Mustang Bio.
Information on this page was last updated on 12/30/2025.

Neil Herskowitz Insider Trading History at Mustang Bio

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
12/30/2025	Sell	247	$0.96	$237.12	145

Neil Herskowitz Buying and Selling Activity at Mustang Bio

Mustang Bio Company Overview

Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline focuses on gene therapy programs for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors. The company develops MB-117 and MB-217, a gene therapy program for X-linked severe combined immunodeficiency, a rare genetic immune system condition in which affected patients do not live beyond infancy without treatment. The company also develops MB-106 CAR T cell program for B cell non-hodgkin lymphoma and chronic lymphocytic leukemia; MB-101 CAR T cell program for glioblastoma; MB-108, a next-generation oncolytic herpes simplex virus. It has license agreements with Nationwide Children's Hospital, CSL Behring; Mayo Clinic; Leiden University Medical Centre; SIRION Biotech GmbH. The company was incorporated in 2015 and is headquartered in Worcester, Massachusetts.

Today's Range

Now: $0.42

$0.38

$0.43

50 Day Range

MA: $0.54

$0.42

$0.61

2 Week Range

Now: $0.42

$0.38

$1.81

Volume

82,313 shs

Average Volume

108,399 shs

Market Capitalization

$3.16 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.09